Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aligos Therapeutics

Request full access

Aligos is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

San Francisco, United StatesFounded 2018Biotech & Life Sciences

About Aligos Therapeutics

Aligos Therapeutics is a biopharmaceutical company focused on developing targeted therapies for chronic liver diseases and viral infections. The company leverages its expertise in small molecule and oligonucleotide platforms to create drug candidates with clinically validated targets and optimized pharmacological characteristics. Aligos aims to address unmet medical needs in conditions such as chronic hepatitis B (CHB), COVID-19, and Nonalcoholic Steatohepatitis (NASH). The company operates in the biopharmaceutical market, primarily serving healthcare providers and patients affected by these diseases. Aligos generates revenue through the development and potential commercialization of its drug candidates, as well as through partnerships and collaborations with other pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2020

Aligos Therapeutics in the San Francisco ecosystem

Live from Dealroom

The Aligos Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States80%
🇨🇳 China2.5%
🇨🇭 Switzerland1.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aligos Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aligos Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.